CervoMed Inc. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
CervoMed Inc. (CRVO) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2024-11-12
- CervoMed Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- CervoMed Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2023-09-30 was 458.40K shares.
- CervoMed Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2022-09-30 was 0.00 shares.
- CervoMed Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2017-09-30 was 20.61K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month |
|---|---|---|
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 |
| 2023-09-30 | 458.40K shares 10-Q · filed 2024-11-12 | 750.99K shares 10-Q · filed 2024-11-12 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-11-13 | 0.00 shares 10-Q · filed 2023-11-13 |
| 2017-09-30 | 20.61K shares 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |